Therapeutic Potentials of Superoxide Dismutase

Overview

Journal Int J Health Sci (Qassim)

Specialty General Medicine

Date 2018 Jun 14

PMID 29896077

Citations 193

Authors

H Younus

Affiliations

Soon will be listed here.

Abstract

Superoxide dismutases (SODs) constitute a very important antioxidant defense against oxidative stress in the body. The enzyme acts as a good therapeutic agent against reactive oxygen species-mediated diseases. The present review describes the therapeutic effects of SOD in various physiological and pathological conditions such as cancer, inflammatory diseases, cystic fibrosis, ischemia, aging, rheumatoid arthritis, neurodegenerative diseases, and diabetes. However, the enzyme has certain limitations in clinical applications. Therefore, SOD conjugates and mimetics have been developed to increase its therapeutic efficiency. Here, an overview is provided of some in vivo therapeutic effects observed with SOD.

Citing Articles

Endothelial dysfunction in chronic obstructive pulmonary disease: an update on mechanisms, assessment tools and treatment strategies.

Marcuccio G, Candia C, Maniscalco M, Ambrosino P Front Med (Lausanne). 2025; 12:1550716.

PMID: 40046916 PMC: 11880998. DOI: 10.3389/fmed.2025.1550716.

The Effect of one-week spinach and NBS superfood supplementation on interleukin-6, superoxide dismutase, and malondialdehyde levels after repeated bouts of wingate test in trained men.

Shirinbayan M, Azizi M, Amiri E Nutr Metab (Lond). 2025; 22(1):18.

PMID: 40012033 PMC: 11866640. DOI: 10.1186/s12986-025-00911-6.

Investigation of calonysterone and 20-hydroxyecdysone effects in high-fat, high-sugar diet-induced obesity rat model.

Osman A, Laczko D, Vagvolgyi M, Seres-Bokor A, Sztojkov-Ivanov A, Kemeny K Heliyon. 2025; 11(3):e42435.

PMID: 39991217 PMC: 11847253. DOI: 10.1016/j.heliyon.2025.e42435.

Investigating intestinal epithelium metabolic dysfunction in celiac disease using personalized genome-scale models.

McCreery C, Alessi D, Mollo K, Fasano A, Zomorrodi A BMC Med. 2025; 23(1):95.

PMID: 39984962 PMC: 11846356. DOI: 10.1186/s12916-025-03854-0.

Potential Mechanisms of Lactate Dehydrogenase and Bovine Serum Albumin Proteins as Antioxidants: A Mixed Experimental-Computational Study.

Ye J, Bounds A, Crumpton M, Long M, McDonough H, Srikhirisawan I Biochem Res Int. 2025; 2025:9638644.

PMID: 39963554 PMC: 11832265. DOI: 10.1155/bri/9638644.

References

Riley D . Functional mimics of superoxide dismutase enzymes as therapeutic agents. Chem Rev. 2001; 99(9):2573-88. DOI: 10.1021/cr980432g. View

Choi J, Rees H, Weintraub S, Levey A, Chin L, Li L . Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem. 2005; 280(12):11648-55. DOI: 10.1074/jbc.M414327200. View

Troy C, Shelanski M . Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc Natl Acad Sci U S A. 1994; 91(14):6384-7. PMC: 44206. DOI: 10.1073/pnas.91.14.6384. View

Saxena A, Srivastava P, Kale R, Baquer N . Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol. 1993; 45(3):539-42. DOI: 10.1016/0006-2952(93)90124-f. View

Rottner M, Tual-Chalot S, Mostefai H, Andriantsitohaina R, Freyssinet J, Martinez M . Increased oxidative stress induces apoptosis in human cystic fibrosis cells. PLoS One. 2011; 6(9):e24880. PMC: 3171475. DOI: 10.1371/journal.pone.0024880. View

Flohe L . Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes. Mol Cell Biochem. 1988; 84(2):123-31. DOI: 10.1007/BF00421046. View

Longo V, Finch C . Evolutionary medicine: from dwarf model systems to healthy centenarians?. Science. 2003; 299(5611):1342-6. DOI: 10.1126/science.1077991. View

Salvemini D, Cuzzocrea S . Superoxide, superoxide dismutase and ischemic injury. Curr Opin Investig Drugs. 2002; 3(6):886-95. View

St Clair D, Oberley T, Muse K, St Clair W . Expression of manganese superoxide dismutase promotes cellular differentiation. Free Radic Biol Med. 1994; 16(2):275-82. DOI: 10.1016/0891-5849(94)90153-8. View

10.

Bravard A, Sabatier L, Hoffschir F, Ricoul M, Luccioni C, Dutrillaux B . SOD2: a new type of tumor-suppressor gene?. Int J Cancer. 1992; 51(3):476-80. DOI: 10.1002/ijc.2910510323. View

11.

Campana F, Zervoudis S, Perdereau B, Gez E, Fourquet A, Badiu C . Topical superoxide dismutase reduces post-irradiation breast cancer fibrosis. J Cell Mol Med. 2004; 8(1):109-16. PMC: 6740277. DOI: 10.1111/j.1582-4934.2004.tb00265.x. View

12.

Ceriello A . Oxidative stress and glycemic regulation. Metabolism. 2000; 49(2 Suppl 1):27-9. DOI: 10.1016/s0026-0495(00)80082-7. View

13.

Mansuroglu B, Derman S, Yaba A, Kizilbey K . Protective effect of chemically modified SOD on lipid peroxidation and antioxidant status in diabetic rats. Int J Biol Macromol. 2014; 72:79-87. DOI: 10.1016/j.ijbiomac.2014.07.039. View

14.

Harman D . Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956; 11(3):298-300. DOI: 10.1093/geronj/11.3.298. View

15.

Massaad C, Washington T, Pautler R, Klann E . Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2009; 106(32):13576-81. PMC: 2726352. DOI: 10.1073/pnas.0902714106. View

16.

Porfire A, Leucuta S, Kiss B, Loghin F, Parvu A . Investigation into the role of Cu/Zn-SOD delivery system on its antioxidant and antiinflammatory activity in rat model of peritonitis. Pharmacol Rep. 2014; 66(4):670-6. DOI: 10.1016/j.pharep.2014.03.011. View

17.

Levin E . Extracellular superoxide dismutase (EC-SOD) quenches free radicals and attenuates age-related cognitive decline: opportunities for novel drug development in aging. Curr Alzheimer Res. 2005; 2(2):191-6. DOI: 10.2174/1567205053585710. View

18.

Inal M, Kanbak G, Sunal E . Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta. 2001; 305(1-2):75-80. DOI: 10.1016/s0009-8981(00)00422-8. View

19.

Li T, Chen G, Su C, Lin J, Yeh C, Cheng K . Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res. 2005; 25(2A):971-9. View

20.

Salem K, McCormick M, Wendlandt E, Zhan F, Goel A . Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma. Redox Biol. 2014; 4:23-33. PMC: 4309843. DOI: 10.1016/j.redox.2014.11.002. View